From the more than 700,000 deaths from COVID-19 in the US and the nearly 5 million worldwide, there emerge even more stories than match the statistics when one considers all of the patients' relations
This research paper shows that a widely used tool might generate substantially divergent cardiovascular disease risk estimates for Black versus White individuals with identical risk profiles, which could introduce race-related variations in clinical recommendations for cardiovascular disease prevention.
This study supports SDG 3 and 10 by identifying multiple structural and normalisation biases in maternity care in the UK that disproportionately affected Black and minority ethnic women who died while receiving maternity care, including lack of nuanced care; microaggressions; and cultural, social, and clinical complexities in the care received.
The aim of this profile is to highlight the impact of George Washington Carver’s contributions to modern plant science and to celebrate his achievements as a pioneering interdisciplinary researcher. By discussing his work, in light of recent discoveries in legume symbioses and soil nutrition, the goal is to reveal his foresight and relevance, inspire new generations from diverse backgrounds and contribute to the decolonisation of the curriculum in higher education.
Elsevier,
iPSCs - State of the Science
Volume 16 in Advances in Stem Cell Biology
2022, Pages 197-224
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by focusing on the uses of iPSCs in inherited diseases and, particularly, in the case of Gaucher disease (GD).
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing information about pituitary adenomas and the complex collection of disorders they produce.
This systematic review explores the effects of exercise on Alzheimer's disease.
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by showing how the issue of “inclusion” could be affected by the advancement of artificial intelligence (AI) in medicine through the interaction between rare diseases (RDs) and AI technology.
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing insights into diagnostic access for undiagnosed and rare diseases in critical care
